Haftar: Paris Meeting is Sarraj’s Last Chance

Libyan General Khalifa Haftar speaks during a news conference in Amman, Jordan August 24, 2015. (Reuters
Libyan General Khalifa Haftar speaks during a news conference in Amman, Jordan August 24, 2015. (Reuters
TT

Haftar: Paris Meeting is Sarraj’s Last Chance

Libyan General Khalifa Haftar speaks during a news conference in Amman, Jordan August 24, 2015. (Reuters
Libyan General Khalifa Haftar speaks during a news conference in Amman, Jordan August 24, 2015. (Reuters

The Commander of the Libyan Army, Field Marshal Khalifa Haftar, cautiously welcomed the meeting he held on Tuesday in Paris with head of the UN-backed Government of National Accord Fayez al-Sarraj under the auspices of French President Emmanuel Macron and in the presence of the new UN envoy to Libya, Ghassan Salame.

In an interview with Asharq Al-Awsat newspaper, Haftar said the joint communiqué, which was issued following the meeting in La Celle-Saint-Cloud near Paris, represented “a set of principles; and we want to deal seriously with the roots of the crisis.”

“There are things that we wished to receive and did not get; but there is no need to go into details,” he added.

Haftar stressed that the meeting held in Paris was Sarraj’s “last chance”, noting: “We will see the extent of his ability to implement the commitments.”

The Libyan army commander seemed to be cautious about the possibility of putting all the items of La Celle-Saint-Clouq communiqué into effect. He noted, however, that a meeting would be held every three months with Macron to follow up on the implementation of the commitments contained in the joint statement.

During Tuesday’s encounter, the two Libyan leaders signed a 10-point declaration, in which they pledged to commit to ceasefire, hold elections and integrate all militias within a unified national army under political control.

Haftar told Asharq Al-Awsat that the statement did not only reflect his views, but also the views of other Libyan parties. He noted in this regard that not all the agreed points were achievable, highlighting however that there was now much seriousness and commitment in dealing with the ongoing crisis.

Haftar expressed confidence in the new international envoy, describing him as a “virtuous and respectable man with a very rich experience”. He strongly criticized the former envoy, Martin Kobler, whom he said was “completely biased, and therefore lost credibility.”

“We were reluctant to deal with him for a while,” he noted.

On whether he believed that Sarraj would abide by his commitments, the army commander said: “That was Sarraj’s last chance; we will see the extent of his ability to implement the commitments.”

Asked about the process to unify the country’s militias under a unified army, Haftar said: “In the eastern region there are no militias; the situation must be resolved in the southern region. In the West, all the military support us.”

Stressing his rejection to any form of foreign interference, the Libyan official said that time was needed to arrange the country’s security situation.

“We want a real state, not a failed state; a country recognized by the international community, whose people can live like the rest of the world,” he stated.

On whether he intends to run for the upcoming presidential elections, Haftar said: “If the people want that, then I will”.

The army commander underlined the importance of adopting a decentralized political system to establish a strong state.

“It shouldn’t be the federal state that some Libyans are talking about … We reaffirm our strong rejection to the partition of the country,” he said, adding: “What we want is an extensive decentralization.”

Haftar noted that the Skhirat agreement, which was signed in Morocco in 2015, has “complicated the problem instead of solving it.”

“We will have a big role in introducing the amendments we want to the agreement, so that it suits the interests of the people,” he stated.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.